What are the timing phases of a contrast‑enhanced CT (CECT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Phases of Contrast-Enhanced CT (CECT) Scan

A standard CECT whole abdomen protocol includes four distinct phases: noncontrast, late arterial (35 seconds post-injection), portal venous (60-70 seconds post-injection), and delayed (90+ seconds post-injection), with specific phase combinations tailored to the clinical indication. 1

Standard Phase Timing and Clinical Utility

Noncontrast Phase

  • Identifies high-attenuation material (calcifications, hemorrhage, ingested material) that could be obscured by contrast enhancement 1
  • Can be replaced with virtual noncontrast series on newer multienergy CT scanners 1

Late Arterial Phase (35 seconds post-injection)

  • Provides optimal arterial opacification for detecting hypervascular lesions and arterial bleeding 1
  • Critical for detecting contrast extravasation in suspected hemorrhage 1
  • The arterial phase begins 10-20 seconds after injection and lasts 25-35 seconds in liver imaging protocols 2
  • Hypervascular liver metastases show early strong enhancement during this phase 2
  • Optimal timing is 10-15 seconds after aortic contrast arrival for early arterial phase hepatic imaging 3

Portal Venous Phase (60-70 seconds post-injection)

  • Most sensitive phase for detecting hypovascular metastases with 85-91.5% sensitivity 1
  • Provides optimal bowel wall enhancement and solid organ evaluation 1
  • The portal venous phase extends from 30-45 seconds to 120 seconds post-injection 2
  • Primary phase for solid organ injury detection in trauma evaluation 1
  • Allows better detection of slow venous bleeding 1

Delayed Phase (90+ seconds post-injection)

  • Enhances lesion characterization and improves detection of slow venous bleeding 1
  • The late phase begins after 120 seconds and ends with bubble disappearance (approximately 5 minutes post-injection) in contrast-enhanced ultrasound 2
  • Most characteristic feature of metastases is hypoechogenicity in the late phase relative to surrounding liver 2

Protocol Selection Based on Clinical Context

Suspected GI Bleeding

  • Use multiphase protocol with noncontrast, late arterial, and portal venous phases 1
  • Achieves 85-90% sensitivity and 92% specificity for detecting active hemorrhage 1
  • Avoid oral contrast as it delays scanning and obscures bleeding 1

Liver Lesion Evaluation

  • Include arterial, portal venous, and delayed phases 1
  • Hypervascular lesions require arterial phase imaging while hypovascular metastases are best detected on portal venous phase 1
  • Rim enhancement during arterial and portal venous phases is valuable for characterizing metastases 2

CT Enterography

  • Contrast-enhanced imaging initiated 50-70 seconds after IV injection, between enteric and portal phases 2
  • Single enteric phase adequate for detecting inflammatory conditions and masses 1
  • Multiphasic examinations improve detection and characterization of vascular lesions 1
  • Requires 900 mL neutral or biphasic enteric contrast administered over 45-60 minutes before scanning 2

Trauma Evaluation

  • Portal venous phase is primary phase for solid organ injury detection 1
  • Dual-phase imaging including arterial phase significantly improves sensitivity and accuracy for splenic vascular injury 1

Critical Technical Considerations

Contrast Administration

  • High injection flow rate (4-5 mL/sec) desirable for arterial phase imaging 4, 5
  • Faster injection rates increase maximum aortic enhancement without decreasing arterial phase duration 6
  • Injection duration is key determinant of equilibrium phase onset 4, 5
  • Use 20-gauge intravenous catheter to avoid microbubble destruction 2

Oral Contrast Selection

  • Neutral oral contrast preferred for small bowel evaluation as it allows better visualization of enhancing lesions 1
  • Positive oral contrast must be avoided in CT enterography as it obscures mucosal hyperenhancement and active hemorrhage 7
  • Avoid oral contrast in suspected GI bleeding 1

Image Acquisition

  • Slice thickness of 2.5-5 mm recommended, with thinner slices improving lesion detection 1
  • ECG gating useful for ascending aorta evaluation where cardiac motion creates artifacts 1

Common Pitfalls to Avoid

  • Never perform noncontrast CT alone for abdominal evaluation as it has significantly lower sensitivity for detecting visceral organ and vascular injuries 1
  • Do not use standard positive oral contrast for CT enterography as it obscures mucosal enhancement patterns 7
  • Avoid phosphate-containing oral preparations in patients with GFR <60 mL/min/1.73 m² due to phosphate nephropathy risk 7
  • Evaluate all vascular phases when assessing focal liver lesions, as artifacts can lead to misinterpretation if only late phase is evaluated 2

References

Guideline

Phases of CECT Whole Abdomen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effects of injection rates of contrast material on arterial phase hepatic CT.

AJR. American journal of roentgenology, 1998

Guideline

Neutral Contrast Agents for CT Enterography

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.